期刊文献+

脑动脉狭窄闭塞患者侧支循环建立的相关影响因素 被引量:3

Related Influencing Factors for Collateral Circulation Formation in Patients with Cerebral Arterial Stenosis / Occlusion
下载PDF
导出
摘要 目的探讨脑动脉狭窄或闭塞患者侧支循环建立相关危险因素。方法脑动脉狭窄或闭塞患者175例,均行全脑血管造影术,分析脑动脉狭窄程度与侧支循环建立的关系及其影响因素。结果侧支循环代偿良好率随脑动脉狭窄程度的增加而升高。单因素分析结果显示代偿良好组吸烟、糖尿病、高脂血症、高血压比例和纤维蛋白原水平明显高于代偿不良组(P<0.05);多因素logistic回归分析结果显示,吸烟,合并糖尿病、高脂血症、高血压,纤维蛋白原是脑动脉狭窄侧支循环的危险因素。结论侧支循环代偿良好率随脑动脉狭窄程度的增加而升高;吸烟,合并糖尿病、高脂血症、高血压,纤维蛋白原是脑动脉狭窄侧支循环的危险因素。 Objective To investigate the related risk factors for collateral circulation formation in patients with cerebral arterial stenosis / occlusion. Methods One hundred and seventy-five patients with cerebral arterial stenosis / occlusion underwent digital subtraction angiography( DSA). The relationship between the degree of cerebral arterial stenosis and collateral circulation formation,and the influencing factors were analyzed. Results The excellent rate of collateral circulation compensation increased with the increasing severity of cerebral arterial stenosis. The results of univariate analysis showed that there were significantly higher ratioes of smoking,diabetes mellitus,hyperlipemia,hypertension and higher level of fibrinogen in the excellent compensation group compared with decompensation group( P〈0. 05). The results of multivariate logistic regression analysis showed that smoking,being complicated with diabetes mellitus,hyperlipemia,hypertension and higher level of fibrinogen were the risk factors for collateral circulation formation in patients with cerebral arterial stenosis. Conclusion The collateral circulation compensation is improved more significantly with the increasing severity of cerebral arterial stenosis. Smoking,being complicated with diabetes mellitus,hyperlipemia,hypertension and higher level of fibrinogen are risk factors for collateral circulation in patients with cerebral arterial stenosis.
作者 梁睿
出处 《广西医学》 CAS 2014年第12期1751-1753,共3页 Guangxi Medical Journal
关键词 脑动脉狭窄 侧支循环 危险因素 Cerebral arterial stenosis Collateral circulation Risk factor
  • 相关文献

参考文献13

  • 1Higashida RT, Furlan A J, Roberts H, et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke [ J ]. Stroke,2003,34 (8) : e109 - 137.
  • 2North American Sympomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collab- orators[J]. N Engl J Med,1991,325(7) :445 -453.
  • 3Hermier M, Ibrahim AS, Wiart M, et al. The delayed perfu- sion sign at MRI [ J ]. J Neuroradio1,2003,30 (3) :172 - 179.
  • 4Harrigan MR. Angiogenie factors in the central nervous sys- tem [ J ]. Neurosurgery, 2003,53 (3) : 639 - 661.
  • 5Henderson RD, Eliasziw M, Fox A J, et al. Angiographically defined collateral circulation and risk of stroke in patients with severe carotid artery stenosis. North American Symptom- atic Carotid Endarterectomy Trial ( NA SCET) Group [ J ]. Stroke ,2000,31 ( 1 ) :128 - 132.
  • 6Higashida R, Furlan A J, Roberts H, et al. Trial design and reporting standards for intraarterial cerebral thrombolysis for acute ischemic stroke [ J ]. J Vasc Interv Radiol, 2003,14 (9 Pt 2) :493 -494.
  • 7Cui X, Chopp M, Zaeharek A, et al. Role of endothelial ni- tric oxide synthetase in arteriogenesis after stroke in mice [ J ]. Neuroscience, 2009,159 (2) :744 - 750.
  • 8Kablak-Ziembieka A, Przewlocki T, Pieniazek P, et al. Evatu- ation of cerebral circulation in patients with significant carotid artery stenosis[ J]. Kardiol Pol,2005,63 (4) :381 - 389.
  • 9Schierling W, Troidl K, Mueller C, et al. Increased intravas- cular flow rate triggers cerebral arteriogenesis [ J ]. J Cereb Blood Flow Metab, 2009,29 (4) : 726 - 737.
  • 10Ng MK, Wu J, Chang E, et al. A central role for nicotinic cholinergic regulation of growth factor-induced endothelial cell migration [ J ]. Arterioscler Thromb Vasc Biol, 2007,27 (1) :106 - 112.

同被引文献49

  • 1翁映虹,黄坚红.阿尔茨海默病评定量表-认知部分中文版与日常生活能力量表评价血管性痴呆的信度与效度[J].中国老年学杂志,2014,34(7):1751-1753. 被引量:122
  • 2Jahansouz C, Kumer SC, Ellenbogen M. Evolution of β-Cell Replace- ment Therapy in Diabetes. Mellitus : Pancreas Transplantation [ J ]. Dia- betes Technol Ther,2014,13 (3) :395-418.
  • 3Speight J, Reaney MD, Woodcock AJ, et al. Patient-reported outcomes following islet cell or pancreas transplantation (alone or after kidney) in Type 1 diabetes: a systematic review [ J]. Diabet Med, 2014,27 (7) :812-822.
  • 4Arndt T, Wedekind D, Weiss H. Prevention of spontaneous immune- mediated diabetes development in the LEW. 1ARl-iddm rat by selec- tive CD8 + T cell transfer is associated with a cytokine shift in the pancreas-draining lymph nodes[ J]. Diabetologia,2013,52(7 ) : 1381- 1390.
  • 5Murgia C, Devirgiliis C, Mancini E. Diabetes-linked zinc transporter ZnT8 is a homodimerie protein expressed by distinct rodent endocrinecell types in the pancreas and other glands [ J ]. Nutr Metab Cardio- vasc Dis,2013,19(6) :431-439.
  • 6Woo SW, Kim JH, Kang HI. High-Dose Simvastatin Is Effective in Pre- venting Cerebral Vasospasm after Aneurysmal Subarachnoid Hemor- rhage:A Prospective Cohort Study in Korean Patients [ J ]. J Korean Neurosurg Soc ,2015,58 (4) :328-333.
  • 7Anthony Jalin AM, Lee JC, Cho GS. Simvastatin Reduces Lipopolysac- charides-Accelerated Cerebral Ischemic Injury via Inhibition of Nucle- ar Factor-kappa B Activity[J]. Biomol Ther,23(6) :531-538.
  • 8Katz PM, Mendelsohn AA, Goodman SG. Use of a treatment optimiza- tion algorithm involving statin-ezetimibe combination aids in achieve- ment of guideline-based low-density lipoprotein targets in patients with dyslipidemia at high vascular risk Guideline-based Undertaking to Im- prove Dyslipidemia Management in Canada ( GUIDANC ) [ J ]. Can J Cardio1,2014,27 (2) : 138-145.
  • 9Couvert P, Chapman MJ, Carri6 A. Impact of genetic variation in the SLCO1 B1 gene on statin efficacy in low-density lipoprotein cholesterol- lowering therapy [ J ]. Pharmacogennmics ,2014,12 ( 2 ) : 137-139.
  • 10Jafri H, Alsheikh-Ali AA, Karas RH. Meta-analysis: statin therapy does not alter the association between low levels of high-density lipo- protein cholesterol and increased cardiovascular risk [ J]. Ann Intern Med,2012,153 (12) :800-808.

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部